Coronavirus Variants Spur FDA To Write New Guidance For COVID-19 Test Developers

The US agency’s immediately-in-effect guidance document – released on 22 February – explains how makers of COVID-19 diagnostics can assess whether their tests are impacted by mutations of the virus.